We are live on ! Find out more
TOVX icon

Theriva Biologics
TOVX

45 hedge funds and large institutions have $70.2M invested in Theriva Biologics in 2015 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 2

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

15% more funds holding

Funds holding: 39 → 45 (+6)

0% more ownership

Funds ownership: 0% → 0% (+0%)

1% less capital invested

Capital invested by funds: $70.6M → $70.2M (-$357K)

Holders
45
Holders Change
+6
Holders Change %
+15.38%
% of All Funds
1.26%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
14
Increased
16
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TS
Third Security
Virginia
+$2.63M
2
William Blair & Company
William Blair & Company
Illinois
+$2.02M
3
MP
MSD Partners
New York
+$1.75M
4
BIT
BlackRock Institutional Trust
California
+$1.65M
5
BGA
Belmont Global Advisors
Texas
+$1.55M

Top Sellers

Rank Fund Capital Flow
1
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$531K
2
TC
TFS Capital
Pennsylvania
-$159K
3
Citadel Advisors
Citadel Advisors
Florida
-$123K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$82K
5
Jane Street
Jane Street
New York
-$70K
Name Holding Trade Value Shares
Change 		Change in
Stake
LTFS
26
Ladenburg Thalmann Financial Services
Florida
$114K +$148K +6 New
VKH
27
Virtu KCG Holdings
New York
$107K +$98.4K +4 +400%
HighTower Advisors
28
HighTower Advisors
Illinois
$97K +$49.2K +2 +67%
Citadel Advisors
29
Citadel Advisors
Florida
$95K -$123K -5 -50%
Creative Planning
30
Creative Planning
Kansas
$84K – – –
M&T Bank
31
M&T Bank
New York
$83K – – –
Millennium Management
32
Millennium Management
New York
$65K -$24.6K -1 -25%
Stifel Financial
33
Stifel Financial
Missouri
$59K +$24.6K +1 +50%
HLA
34
Hamilton Lane Advisors
Pennsylvania
$54K – – –
MWM
35
Mission Wealth Management
California
$53K +$73.8K +3 New
WS
36
Wedbush Securities
California
$50K +$49.2K +2 +200%
TDC
37
Thompson Davis & Co
Virginia
$45K – – –
BA
38
BlackRock Advisors
Delaware
$31K – – –
GA
39
Geneva Advisors
Illinois
$31K +$49.2K +2 New
Bank of America
40
Bank of America
North Carolina
$29K – – –
GC
41
Guggenheim Capital
Illinois
$29K +$24.6K +1 New
BIM
42
BlackRock Investment Management
Delaware
$25K – – –
Wells Fargo
43
Wells Fargo
California
$25K +$24.6K +1 New
Fisher Asset Management
44
Fisher Asset Management
Washington
$24K +$24.6K +1 New
TWA
45
TCI Wealth Advisors
Arizona
$12K – – –
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$7K – – –
TRCT
47
Tower Research Capital (TRC)
New York
$7K – – –
Citigroup
48
Citigroup
New York
$3K – – –
Deutsche Bank
49
Deutsche Bank
Germany
$2K – – –
KF
50
Krilogy Financial
Missouri
$2K – – –
1
2
3

TOVX Hedge Fund Activity: Q3 2015 in Review

45 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Theriva Biologics (TOVX) for Q3 2015, worth a combined $70.2M — down 0.51% from $70.6M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new TOVX positions and 7 closed out — a net gain of 7 holders — while 16 added to existing stakes and 2 trimmed.

The largest buyer was Third Security, adding an estimated $2.63M. The largest seller was Janney Montgomery Scott, exiting entirely with an estimated $531K sold.

  • 45 institutional investors held Theriva Biologics (TOVX) as of Q3 2015, up from 39 in Q2 2015.
  • Funds reported $70.2M of Theriva Biologics stock for Q3 2015, down 0.51% quarter-over-quarter.
  • 14 funds opened new Theriva Biologics positions in Q3 2015 and 7 closed out, a net change of +7 holders.
  • The largest Theriva Biologics buyer in Q3 2015 was Third Security, an estimated $2.63M added.
  • The largest Theriva Biologics seller in Q3 2015 was Janney Montgomery Scott, an estimated $531K sold.

Based on aggregated 13F filings for Q3 2015.